NCT05169112View on ClinicalTrials.gov

Impact of Hormonal Therapy on Prostate Cancer Recurrence After Radical Prostatectomy

PHASE3RecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

March 6, 2023

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2028

Conditions
Prostate Cancer
Interventions
DRUG

Lupron Depot

Patients randomized to receive androgen deprivation therapy (ADT) will receive 12 months of Lupron Depot (22.5 mg) administered every 3 months

Trial Locations (3)

B3H 2Y9

RECRUITING

Nova Scotia Health, Halifax

K1H 8L6

RECRUITING

The Ottawa Hospital, Ottawa

H4A 3J1

NOT_YET_RECRUITING

Centre universitaire de santé McGill - McGill University Health Centre, Montreal

Sponsors
All Listed Sponsors
collaborator

Tolmar Pharmaceuticals

UNKNOWN

lead

Ottawa Hospital Research Institute

OTHER